FRACTYL HEALTH, INC. (GUTS)
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.
Sector: Surgical & Medical Instruments & Apparatus
Industry: Biotechnology
Fractyl Health, Inc.
NASDAQ:GUTSHealthcare · Biotechnology
-1.51%$0.9765
AH$0.9800+0.36%vs close
Mkt Cap$12.95M
Float12.38M
O/S13.26M
Vol
$ Vol
RVOL
Inst Own44.5%
SI2.1%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$140.95M
Total Assets$121.4M
Free Cash Flow-$90.89M
Debt & Equity
Debt 87%
Equity 13%
Total Debt$61.65M
Total Equity$9.46M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
2-year cumulative
1:12
Nasdaq bars a compliance period at 1:250
- 1:12Reverse splitOct 5, 202612 shares → 1
Balance Sheet Details
Assets$121.4M
Liabilities$111.94M
Accounts Receivable$0
Accounts Payable$1.57M
Inventory$0
PP&E (Net)$29.23M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Revenue | $0 | $93K | $120K | $0 | $0 | $0 | $0 |
| YoY Growth | - | -22.5% | - | - | - | - | - |
| Cost of Revenue | $0 | $50K | $77K | $452K | $0 | $770K | $893K |
| Gross Profit | $0 | $43K | $43K | -$452K | $0 | -$770K | -$893K |
| Gross Margin | - | 46.2% | 35.8% | - | - | - | - |
| Research and Development | $74.54M | $70.47M | $38.04M | $34.35M | $26.43M | $22.43M | $20.89M |
| Selling, General, and Administrative | $22.28M | $0 | $0 | $14.58M | $10.49M | $5.76M | $8.14M |
| Other | $0 | $23.1M | $12.84M | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $96.82M | $93.57M | $50.88M | $48.93M | $36.93M | $28.19M | $29.03M |
| Operating Income (EBIT) | -$96.82M | -$93.53M | -$50.84M | -$49.38M | -$36.93M | -$28.96M | -$29.92M |
| Operating Margin | - | -100571.0% | -42363.3% | - | - | - | - |
| Interest Expense | $0 | $0 | $0 | $0 | $1.44M | $1.5M | $635K |
| Interest Income | $1.54M | $4.15M | $1.26M | $797K | $0 | $0 | $0 |
| Other Income (Expense) | -$44.14M | $24.84M | -$26.25M | $2.93M | -$1.81M | -$1.52M | -$673K |
| Income Before Tax (EBT) | -$140.95M | -$68.69M | -$77.09M | -$46.45M | -$38.73M | -$30.48M | -$30.59M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$140.95M | -$68.69M | -$77.09M | -$46.45M | -$38.73M | -$30.48M | -$30.59M |
| Net Income Margin | - | -73864.5% | -64242.5% | - | - | - | - |
| Supplementary Data | |||||||
| EPS | -11.04 | -19.44 | -23.76 | -16.08 | -13.44 | -10.32 | -7.68 |
| Diluted EPS | -11.04 | -19.44 | -23.76 | -16.08 | -13.44 | -10.32 | -7.68 |
| Weighted Average OS | 12.78M | 3.63M | 3.97M | 3.97M | 3.97M | 3.97M | 3.97M |
| EBITDA | -$139.82M | -$68.02M | -$76.81M | -$46M | -$36.62M | -$28.19M | -$29.03M |
| EBITDA Margin | - | -73136.6% | -64004.2% | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Assets | |||||||
| Current Assets | |||||||
| Cash and Cash Equivalents | $81.54M | $67.46M | $33.52M | $49.27M | $95.47M | $29.11M | $5.79M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $81.54M | $67.46M | $33.52M | $49.27M | $95.47M | $29.11M | $5.79M |
| Accounts Receivable | $0 | $0 | $22K | $0 | $0 | $0 | $0 |
| Inventory | $0 | $73K | $73K | $0 | $0 | $0 | $0 |
| Other Current Assets | $6.04M | $4.23M | $2.03M | $2.36M | $915K | $0 | $0 |
| Total Current Assets | $87.58M | $71.76M | $35.65M | $51.63M | $96.39M | $30.88M | $6.78M |
| Long-Term Assets | |||||||
| Property, Plant & Equipment Net | $29.23M | $31.39M | $30.77M | $1.65M | $1.34M | $1.36M | $2.12M |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $835K | $863K | $0 | $0 | $0 |
| Long-Term Investments | $4.25M | $4.25M | $4.25M | $4.25M | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $337K | $666K | $4.7M | $2.56M | $4.82M | $2.52M | $32K |
| Total Long-Term Assets | $33.83M | $36.31M | $40.56M | $9.33M | $6.16M | $3.88M | $2.16M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $121.4M | $108.08M | $76.21M | $60.96M | $102.55M | $34.76M | $8.93M |
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts Payable | $1.57M | $3.24M | $553K | $980K | $970K | $304K | $608K |
| Short-Term Debt | $5.1M | $0 | $2.73M | $0 | $15.72M | $7.17M | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | -$980K | -$970K | $0 | $0 |
| Other Current Liabilities | $6M | $7.39M | $4.4M | $3.3M | $5.13M | $672K | $1.94M |
| Total Current Liabilities | $18.33M | $19.77M | $11.19M | $7.31M | $23.65M | $10.92M | $3.41M |
| Long-Term Liabilities | |||||||
| Long-Term Debt | $30.59M | $30.16M | $342.48M | $305.09M | $287.33M | $8.12M | $14.9M |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $37.07M | $2.33M | $19.1M | $409K | $555K | $769K | $134.62M |
| Total Long-Term Liabilities | $93.61M | $59.88M | $390.09M | $305.96M | $288.22M | $8.89M | $149.52M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $111.94M | $79.65M | $401.27M | $313.27M | $311.87M | $19.81M | $152.93M |
| Stockholders' Equity | |||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $187.67M | $133.11M |
| Common Stock | $1K | $0 | $0 | $0 | $0 | $0 | $20.75M |
| Retained Earnings | -$556.26M | -$415.31M | -$346.62M | -$269.52M | -$223.07M | -$184.34M | -$153.86M |
| Comprehensive Income & Other | $0 | $0 | $0 | $0 | $0 | $0 | -$153.86M |
| Other Stockholders' Equity | $565.72M | $443.73M | $21.55M | $17.21M | $13.75M | $199.29M | -$10.88M |
| Total Equity | $9.46M | $28.42M | -$325.06M | -$252.32M | -$209.32M | $14.95M | -$144M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $121.4M | $108.08M | $76.21M | $60.96M | $102.55M | $34.76M | $8.93M |
| Supplementary Data | |||||||
| Total Debt | $61.65M | $62.5M | $373.72M | $306.81M | $304.34M | $15.29M | $14.9M |
| Net Debt | -$19.89M | -$4.96M | $340.2M | $257.54M | $208.87M | -$13.81M | $9.11M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Operating Activities | |||||||
| Net Income | -$140.95M | -$68.69M | -$77.09M | -$46.45M | -$38.73M | -$30.48M | -$30.59M |
| Depreciation & Amortization | $1.13M | $677K | $286K | $452K | $676K | $770K | $893K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $6.68M | $14.43M | $4.3M | $3.14M | $2.09M | $1.63M | $2.52M |
| Changes in Working Capital: | |||||||
| Accounts Receivable | $0 | $22K | -$22K | $0 | $0 | $0 | $0 |
| Inventory | $73K | $0 | -$73K | $0 | $0 | $0 | $0 |
| Accounts Payable | -$1.67M | $2.69M | -$427K | $0 | $666K | -$304K | $0 |
| Other Working Capital | $1.2M | $6.88M | $1.51M | -$1.24M | $1.04M | -$3.2M | -$824K |
| Total Working Capital Change | -$395K | $9.59M | $989K | -$1.24M | $1.71M | -$3.51M | -$824K |
| Other Non-Cash Items | $43.21M | -$21.52M | $28.7M | -$2.14M | $795K | $517K | $274K |
| Net Cash from Operating | -$90.33M | -$65.52M | -$42.82M | -$46.24M | -$33.46M | -$31.07M | -$27.73M |
| Investing Activities | |||||||
| Capital Expenditures | -$557K | -$1.76M | -$359K | -$56K | -$51K | -$2K | -$97K |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Investing | -$557K | -$1.76M | -$359K | -$56K | -$51K | -$2K | -$97K |
| Financing Activities | |||||||
| Debt Repaid | $457K | $187K | -$28.35M | -$4.03M | $7K | $7K | -$14.95M |
| Common Stock Issuance | $105.42M | $103.69M | $0 | $321K | $0 | $0 | $217K |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | -$2.28M | -$911K | $0 | $40K | $24K | $217K |
| Net Cash from Financing | $104.96M | $101.23M | $27.44M | $4.35M | $99.88M | $54.39M | $15.16M |
| Forex Effect | $0 | $0 | $0 | -$4.25M | $0 | $0 | $0 |
| Net Change in Cash | $14.08M | $33.94M | -$15.74M | -$46.2M | $66.37M | $23.32M | -$12.66M |
| Supplementary Data | |||||||
| Operating Cash Flow | -$90.33M | -$65.52M | -$42.82M | -$46.24M | -$33.46M | -$31.07M | -$27.73M |
| Capital Expenditure | -$557K | -$1.76M | -$359K | -$56K | -$51K | -$2K | -$97K |
| Free Cash Flow | -$90.89M | -$67.29M | -$43.18M | -$46.3M | -$33.51M | -$31.07M | -$27.83M |
| Cash at Beginning | $71.72M | $37.78M | $53.52M | $95.47M | $29.11M | $5.79M | $18.46M |
| Cash at End | $85.8M | $71.72M | $37.78M | $49.27M | $95.47M | $29.11M | $5.79M |